Skip to content

Clinical study on efficacy of Aragvadadhi Kashaya and Amruthadi Kashaya internally with Sarshapa Taila as external application in management of Sheetapitta(Urticaria)

To study the efficacy of Aragvadadhi Kashaya and Amruthadi Kashaya with Sarshapa Taila in management of Sheetapitta- A randomized controlled clinical study - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102609
Enrollment
30
Registered
2026-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L508- Other urticaria

Interventions

None listed

Sponsors

Dr Nikitha Srinivas
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with classical lakshana of Sheetapitta Varati Damshta Samsthana Shotha or Inflammation like an insect bite Kandu or Severe itching Kshanikotpattivinash or Transient With or without Toda or Excessive pain like pricking Vidaha or Burning Sensation Sa utsanga Saraga Mandala or Red Patches Subjects with either sex irrespective of religion within the age group of 20-60years Chronic spontaneous urticaria with duration greater than 6 weeks Subjects who are willing to sign consent form voluntarily Associated symptoms if any Pipasa or Excessive thirst Jvara or Fever Chardi or Vomiting Vibandha or Constipation Raktalochanata or Reddish discoloration of the eyes Dehasada or Tiredness of the body

Exclusion criteria

Exclusion criteria: Subjects suffering from serious systemic disorders that can interfere with the course of treatment like uncontrolled diabetes mellitus uncontrolled hypertension SLE Malignancy AIDS Subjects suffering from Angio edema Subjects who are pregnant lactating women Subjects who are on steroid medications Acute urticaria less than 6 weeks

Design outcomes

Primary

MeasureTime frame
Significant improvement noticed in reduction in signs and symptoms based on Urticaria Activity Score.Timepoint: 0th day,15th day,31st day,45th day.

Secondary

MeasureTime frame
Significant improvement noticed in the Quality of life of patient based on Dermatological Quality of Life Questionnaire. (DLQI scale)Timepoint: 0th day,15th day,31st day,45th day.

Countries

India

Contacts

Public ContactDr Nikitha Srinivas

Shri Dharmasthala Manjunatheswara Institute of Ayurveda and Hospital,Bengaluru

priyabhat@sdmayurbangalore.in9986451162

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026